✦ LIBER ✦

Study of binding and neutralising antibodies to interferon-β in two groups of relapsing-remitting multiple sclerosis patients

✍ Scribed by Oscar Fernández; Cristobalina Mayorga; Gloria Luque; Miguel Guerrero; Rocío Guerrero; Laura Leyva; Antonio León; Miguel Blanca

Publisher: Springer
Year: 2001
Tongue: English
Weight: 259 KB
Volume: 248
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s004150170178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Defining the response to interferon-β in

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

✍ Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raúl Pelayo; Ma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Occurrence of thyroid autoimmunity in re

Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-β treatment

✍ V. Martinelli; M. Gironi; M. Rodegher; G. Martino; G. Comi 📂 Article 📅 1998 🏛 Springer Milan 🌐 English ⚖ 265 KB

Predictive factors of neutralizing antib

Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

Synergistic immunomodulatory effects of

Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis

✍ Frank Weber; Thomas Polak; Astrid Günther; Boris Kubuschok; Julia Janovskaja; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

Magnetic resonance imaging outcome of ne

Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon β1a

✍ Andrea Paolillo; S. Bastianello; Marco Frontoni; Claudio Gasperini; Elisabetta G 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 58 KB

Efficacy and tolerability of natalizumab

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB